Gf Fund Management Co. Ltd. Biotechnology

Gf Fund Management Co. Ltd.

$4.62 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TRVI Trevi Therapeutics, Inc.	$285M	$6.65 Million 0.0% of portfolio	1,614	Q4 2024 New
VYGR Voyager Therapeutics, Inc.	$163M	$6.5 Million 0.0% of portfolio	1,147	Q4 2024 New
ABSI Absci Corp	$461M	$6.32 Million 0.0% of portfolio	2,412	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$257M	$5.94 Million 0.0% of portfolio	1,773	Q4 2024 New
ITOS I Teos Therapeutics, Inc.	$264M	$5.89 Million 0.0% of portfolio	767	Q4 2024 New
VNDA Vanda Pharmaceuticals Inc.	$251M	$5.86 Million 0.0% of portfolio	1,224	Q4 2024 New
ACIU Ac Immune Sa	$221M	$5.61 Million 0.0% of portfolio	2,077	Q4 2024 New
FHTX Foghorn Therapeutics Inc.	$218M	$5.51 Million 0.0% of portfolio	1,167	Q4 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$193M	$5.44 Million 0.0% of portfolio	1,439	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$150M	$5.41 Million 0.0% of portfolio	971	Q4 2024 New
CCCC C4 Therapeutics, Inc.	$147M	$5.34 Million 0.0% of portfolio	1,482	Q4 2024 New
LRMR Larimar Therapeutics, Inc.	$138M	$5.19 Million 0.0% of portfolio	1,340	Q4 2024 New
IGMS Igm Biosciences, Inc.	$40M	$4.38 Million 0.0% of portfolio	716	Q4 2024 New
MGNX Macrogenics Inc	$170M	$4.28 Million 0.0% of portfolio	1,318	Q4 2024 New
ALEC Alector, Inc.	$154M	$4.05 Million 0.0% of portfolio	2,145	Q4 2024 New
FATE Fate Therapeutics Inc	$138M	$3.95 Million 0.0% of portfolio	2,391	Q4 2024 New
INZY Inozyme Pharma, Inc.	$50.2M	$3.74 Million 0.0% of portfolio	1,349	Q4 2024 New
SCPH Sc Pharmaceuticals Inc.	$89.1M	$3.72 Million 0.0% of portfolio	1,051	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$51.5M	$3.71 Million 0.0% of portfolio	2,594	Q4 2024 New
NKTX Nkarta, Inc.	$99.7M	$3.69 Million 0.0% of portfolio	1,482	Q4 2024 New
STRO Sutro Biopharma, Inc.	$92.3M	$3.19 Million 0.0% of portfolio	1,731	Q4 2024 New
TSVT 2seventy Bio, Inc.	$98.9M	$3.18 Million 0.0% of portfolio	1,083	Q4 2024 New
TCRX T Scan Therapeutics, Inc.	$42.2M	$3.13 Million 0.0% of portfolio	1,031	Q4 2024 New
BMEA Biomea Fusion, Inc.	$101M	$3.04 Million 0.0% of portfolio	784	Q4 2024 New
PEPG Pep Gen Inc.	$32.4M	$2.59 Million 0.0% of portfolio	684	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$166M	$2.56 Million 0.0% of portfolio	445	Q4 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$2.54 Million 0.0% of portfolio	1,412	Q4 2024 New
EDIT Editas Medicine, Inc.	$132M	$2.32 Million 0.0% of portfolio	1,830	Q4 2024 New
PYXS Pyxis Oncology, Inc.	$47M	$1.95 Million 0.0% of portfolio	1,249	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.